Detailed Information on Publication Record
2014
Improvement in Quality of Life After Catheter Ablation for Paroxysmal Versus Long-standing Persistent Atrial Fibrillation: A Prospective Study With 3-Year Follow-up
BULKOVÁ, Veronika, Martin FIALA, Štěpán HAVRÁNEK, Jan ŠIMEK, Libor ŠKŇOUŘIL et. al.Basic information
Original name
Improvement in Quality of Life After Catheter Ablation for Paroxysmal Versus Long-standing Persistent Atrial Fibrillation: A Prospective Study With 3-Year Follow-up
Authors
BULKOVÁ, Veronika (203 Czech Republic), Martin FIALA (203 Czech Republic, belonging to the institution), Štěpán HAVRÁNEK (203 Czech Republic), Jan ŠIMEK (203 Czech Republic), Libor ŠKŇOUŘIL (203 Czech Republic), Jaroslav JANUŠKA (203 Czech Republic), Jindřich ŠPINAR (203 Czech Republic, guarantor, belonging to the institution) and Dan WICHTERLE (203 Czech Republic)
Edition
Journal of the American Heart Association, Hoboken, Wiley-Blackwell, 2014, 2047-9980
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30201 Cardiac and Cardiovascular systems
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 4.306
RIV identification code
RIV/00216224:14110/14:00078476
Organization unit
Faculty of Medicine
UT WoS
000341296600016
Keywords in English
atrial fibrillation; long-standing persistent; paroxysmal; quality of life
Tags
Tags
International impact, Reviewed
Změněno: 19/1/2015 11:53, Soňa Böhmová
Abstract
V originále
Background-Changes in quality of life (QoL) after catheter ablation for long-standing persistent atrial fibrillation (LSPAF) are not well described. We sought to compare QoL improvement after catheter ablation of paroxysmal atrial fibrillation (PAF) versus that after LSPAF. Methods and Results-A total of 261 PAF and 126 LSPAF ablation recipients were prospectively followed for arrhythmia recurrence, QoL, hospital stay, and sick leave. In PAF versus LSPAF groups, 1.3 +/- 0.6 versus 1.6 +/- 0.7 procedures were performed per patient (P<0.00001) during a 3-year follow-up. Good arrhythmia control was achieved in 86% versus 87% of patients (P=0.69) and in 69% versus 69% of patients not receiving antiarrhythmic drugs (P=0.99). The baseline QoL was better in the PAF than in the LSPAF group (European Quality of Life Group instrument self-report questionnaire visual analog scale: 66.4 +/- 14.2 versus 61.0 +/- 14.2, P=0.0005; European Quality of Life Group 3-level, 5-dimensional descriptive system: 71.4 +/- 9.2 versus 67.7 +/- 13.8, P=0.002). Postablation 3-year increase in QoL was significant in both groups (all P<0.00001) and significantly lower in PAF versus LSPAF patients (visual analog scale: +5.0 +/- 14.5 versus +10.2 +/- 12.8, P=0.001; descriptive system: +5.9 +/- 14.3 versus +9.3 +/- 13.9, P=0.03). In multivariate analysis, LSPAF, less advanced age, shorter history of AF and good arrhythmia control were consistently associated with postablation 3-year improvement in QoL. Days of hospital stay for cardiovascular reasons and days on sick leave per patient/year were significantly reduced in both groups. Conclusions-Patients with LSPAF had worse baseline QoL. The magnitude of QoL improvement after ablation of LSPAF was significantly greater compared with after ablation of PAF, particularly when good arrhythmia control was achieved without the use of antiarrhythmic drugs.